Search results
Results from the WOW.Com Content Network
Successful treatment of the demyelination process that affects the brain with either stem cell transplant or gene therapy does not immediately normalize the VLCFA levels in body tissues. [7] The levels of VLCFA can be normalized by treatment with Lorenzo's oil , but this does not alter the progression of the disease. [ 2 ]
Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. [30] [28] For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma, and renal-cell carcinoma. [31]
Treatment may involve a team of specialists. This would include neurologists, endocrinologists, and pediatricians. [citation needed] Early intervention is important when treating someone with these disorders. Special education, physical therapy, and other medical services to aid the child through treatment. There are medical trials taking place ...
Some specific symptoms vary from one type of leukodystrophy to the next, but the vast majority of symptoms are shared as the causes for the disease generally have the same effects. Symptoms are dependent on the age of onset, which is predominantly in infancy and early childhood, although the exact time of onset may be difficult to determine.
Elivaldogene autotemcel, sold under the brand name Skysona, is a gene therapy used to treat cerebral adrenoleukodystrophy (CALD). It was developed by Bluebird Bio and was given breakthrough therapy designation by the US Food and Drug Administration in May 2018.
What causes growth hormone deficiency? GHD is a relatively rare condition. Slowed growth, short stature, and low blood glucose levels in infants and toddlers are among a few signs of GH deficiency ...
"A single vehicle has the potential to cause a large mass casualty incident that overwhelms local and mutual aid resources," he wrote in his analysis. "Additionally, the traumatic injuries that ...
A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start ...